Email: RWDassets@iqvia.com
N/A
To find publications please visit: https://www.imsrwebibliography.com/ or contact IQVIA.
Email: RWDassets@iqvia.com
N/A
To find publications please visit: https://www.imsrwebibliography.com/ or contact IQVIA.
Email: RWDassets@iqvia.com
N/A
To find publications, please visit: https://www.imsrwebibliography.com/ or contact IQVIA for the most recent publications.
N/A
N/A
To find publications, please visit: https://www.imsrwebibliography.com/ or contact IQVIA.
N/A
N/A
To find publications, please visit: https://www.imsrwebibliography.com/ or contact IQVIA.
The Swedish Arthroplasty Register (SAR) is a National Quality Register. It is a merger of the two oldest national arthroplasty registers, the Swedish Knee Arthroplasty Register and the Swedish Hip Arthroplasty Register, including knee replacements since 1975, hip replacements since 1979, hemiarthroplasties since 2005, and knee osteotomies since 2013. Reoperations, revisions and other procedures, related to the knee or hip are registered, as well as patient-reported outcome(s).
Professor Ola Rolfson
The Swedish Arthroplasty Register
413 45 Gothenburg
SWEDEN
Email: ola.rolfson@vgregion.se
The Swedish Arthroplasty Register
413 45 Gothenburg
SWEDEN
Phone: +46 10 441 29 31
Email: slr@registercentrum.se
1. Jolbäck P, Bedeschi Rego De Mattos C, Rogmark C, Chen AF, Nauclér E, Tsikandylakis G. Patient-reported Outcomes After Primary Total Hip Arthroplasty Are Not Affected by the Sex of the Surgeon: A Register-based Study of 8,383 Procedures in Western Sweden. J Am Acad Orthop Surg. 2023 Jul 1;31(13):692-700.
2. Dale H, Fenstad AM, Hallan G, Overgaard S, Pedersen AB, Hailer NP, Kärrholm J, Rolfson O, Eskelinen A, Mäkelä KT, Furnes O. Increasing risk of revision due to infection after primary total hip arthroplasty: results from the Nordic Arthroplasty Register Association. Acta Orthop. 2023 Jun 27;94:307-315.
3. Gustafsson K, Kvist J, Eriksson M, Rolfson O. What Factors Identified in Initial Osteoarthritis Management Are Associated With Poor Patient-reported Outcomes After THA? A Register-based Study. Clin Orthop Relat Res. 2023 May 9;481(9):1732–42.
4. Itayem R, Rolfson O, Mohaddes M, Kärrholm J. What is the Role of Stem Size and Offset in the Risk of Nonseptic Revision of the Exeter® 150-mm Stem? A Study From the Swedish Arthroplasty Register. Clin Orthop Relat Res. 2023 Apr 28;481(9):1689–99.
5. Ighani Arani P, Wretenberg P, Stenberg E, Ottosson J, W-Dahl A. Total knee arthroplasty and bariatric surgery: change in BMI and risk of revision depending on sequence of surgery. BMC Surg. 2023 Mar 10;23(1):53.
6. Lagergren J, Mukka S, Wolf O, Nauclér E, Möller M, Rogmark C. Conversion to Arthroplasty After Internal Fixation of Nondisplaced Femoral Neck Fractures: Results from a Swedish Register Cohort of 5,428 Individuals 60 Years of Age or Older. J Bone Joint Surg Am. 2023 Mar 1;105(5):389-396.
7. Cöster MC, Bremander A, Nilsdotter A. Patient-reported outcome for 17,648 patients in 5 different Swedish orthopaedic quality registers before and 1 year after surgery: an observational study. Acta Orthop. 2023 Jan 23;94:1-7.
8. Jolbäck P, Mukka S, Wetterling K, Mohaddes M, Garland A. Patient-surgeon sex discordance impacts adverse events but does not affect patient-reported satisfaction after primary total hip arthroplasty: a regional register-based cohort study. Acta Orthop. 2022 Dec 27;93:922–9.
9. Thompson O, W-Dahl A, Stefánsdóttir A. Increased short- and long-term mortality amongst patients with early periprosthetic knee joint infection. BMC Musculoskelet Disord. 2022 Dec 6;23(1):1069.
10. Rönnquist SS, Lagergren J, Viberg B, Möller M, Rogmark C. Rate of conversion to secondary arthroplasty after femoral neck fractures in 796 younger patients treated with internal fixation: a Swedish national register-based study. Acta Orthop. 2022 Jun 14;93:547-553.
Started in 2014, STATinMED’s licensed all-payer medical, and pharmacy claims dataset (STATinMED Real World Data Insights) provides insight into approximately 80% of the US healthcare system. These data are comparable with other all-payer claims repositories as they are sourced directly from claims clearinghouses, which are responsible to manage claims transactions between payers and providers, offering comprehensive coverage at the patient level across the US healthcare system.
Keshia Maughn
SVP/Principal, RWE (STATinMED RWD Insights)
STATinMED, LLC
13101 Preston Rd Suite 110, #3395
Dallas, TX 75240
USA
Phone:+1 214-480-4946
Email: kmaughn@statinmed.com
N/A
1. Shoaib S, Feliciano J, Dasenbrook EC, Maynard J, Batchu L, Mohanty M, Lauterio M, Feld AJ. Real-world disease burden, mortality, and healthcare resource utilization associated with bronchiectasis. Chron Respir Dis. 2025 Jan-Dec;22:14799731241310897.
2. Vo R, Barhoush Y, Batchu L, Adams S, Setzen G. All-cause claims analysis of the LATERA absorbable nasal implant vs surgical repair in patients with nasal valve collapse. J Med Econ. 2024 Jan-Dec;27(1):1099-1107.
3. Seigel L, Shoaib S, Maughn K, Foster M, Shah S, Batchu L, Wittstock K, Alexis A. Health disparities in psoriasis: geographic barriers to access in the United States. J Dermatolog Treat. 2024 Dec;35(1):2365820.
4. Zhao R, Ding Z, Gupta P, Gozalo L, Bruette R, Johnson VM, Maughn K, Liu Y, Kachroo S. Evaluation of Treatment Patterns and Maintenance Dose Titration Among Patients With Crohn's Disease Initiating Biologics With 3 Years of Follow-Up. J Health Econ Outcomes Res. 2023 Nov 20;10(2):111-120.
5. Navari RM, Nelson WW, Shoaib S, Singh R, Zhang W, Bailey WL. Real-World Treatment Outcomes, Healthcare Resource Use, and Costs Associated with Antiemetics Among Cancer Patients on Cisplatin-Based Chemotherapy. Adv Ther. 2023 Jul;40(7):3217-3226.
6. Escobar M, Bullano M, Mokdad AG, Caicedo J, Schultz BG, Fan Q, Verma S. A real-world evidence analysis of the impact of switching from factor VIII to emicizumab prophylaxis in patients with hemophilia A without inhibitors. Expert Rev Hematol. 2023 Jun;16(6):467-474.
7. Terrault N, Dieyi C, Trivedi R, Coppola R, Maynard J, Reau N, Satram S, Chattergoon M. Prevalence of hepatitis B and D virus among a nationally representative insured population in the United States. AASLD The Liver Meeting. Boston, MA: Nov 10-14, 2023.
8. Karlitz J, Liu Y, Gupta P, Aweh G, Chung K. Burden of liver cancer among Medicaid-insured patients: A retrospective analysis of a national all-payer claims database. American College of Gastroenterology (ACG) Annual Scientific Meeting. Vancouver, CA: Oct 20-25, 2023.
9. Holman D, Drayton D, Pandit M, Diaz A, Maughn K, Dieyi C, Achter E, Peeples H. Effects of insurance coverage and antiseizure medication formulary policies on the experiences of patients with epilepsy and healthcare professionals: A qualitative study. Academy of Managed Care Pharmacy (AMCP) Nexus 2023. Orlando, FL: Oct 16-19, 2023.
10. Chung KC, Karlitz J, Liu Y, Gupta P, Aweh G. Cancer incidence among the Medicaid population: A retrospective analysis of a national all-payer claims database. Academy of Managed Care Pharmacy (AMCP) Nexus 2023. Orlando, FL: Oct 16-19, 2023.
